MSC Certificate Place and date: For the issuing office: Shanghai, 20 March 2024 DNV - Business Assurance Building 9, No. 1591 Hongqiao Road, Changning DistrictShanghai China 200336 Zhu Hai Ming Management Representative Lack of fulfilment of conditions as set out in the Certification Agreement may render this Certificate invalid.

We use a set of formal quality tools and systems in evaluating and tracking quality complaints. Avient has set a system to backup critical data. Material management Raw materials used in Avient healthcare applications must fulfill a minimum set of requirements.

These investments also consider our global footprint, and we are positioned very well and strategically from a regional perspective. 12 Growth Drivers 2020 Revenue ($ Millions) Long-Term Growth Rate Sustainable Solutions $ 560 8–12% Healthcare 555 8–10% Composites / 5G 212 10% Growth in Emerging Regions 672 5% Other (GDP growth) 1,784 2–3% Pro Forma Avient $ 3,783 6.5% Q 1 2021 P E RFO R MA N CE U P DAT E $86 $123 2020PF 2021 $0.53 $0.89 2020PF 2021 Q1 2021 – ORGANIC PERFORMANCE (TOTAL COMPANY) 14 Sales Adjusted Operating Income $991 $1,162 2020PF 2021 + 17% Adjusted EPS + 43% + 68% (in millions) (in millions) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q1 2021 SEGMENT PERFORMANCE 15 CAI $536 $609 Sales ($ in millions) SEM Distribution $64 $89 Operating Income (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition +14% +39% $290 $363 Sales $19 $24 Operating Income +25% +26% (1) $185 $217 Sales $22 $34 Operating Income +17% +55% SPECIALTY EBITDA MARGIN EXPANSION 16 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 15.3% 15.2% 16.2% 19.1% 2018 2019 2020 Q1 2021 14.8% 15.2% 17.6% 19.4% 2018 2019 2020 Q1 2021 (1) SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Masterbatch synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 17 Legacy CAI 18.9% 18.9% 21.0% 2019 2020 Q1 2021 Legacy Clariant MB 11.9% 13.8% 17.4% 2019 2020 Q1 2021 • Early synergy capture translating to the bottom line • Positive mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 36% represents sales from products introduced in the last five years.

Q 3 2021 P E RFO R MA N CE U P DAT E $74 $99 2020 2021 $0.46 $0.70 2020 2021 Q3 2021 PERFORMANCE (TOTAL COMPANY) 4 Sales Adjusted Operating Income $925 $1,220 2020 2021 + 32% Adjusted EPS + 34% + 52% (in millions) (in millions) Q3 2021 SEGMENT PERFORMANCE 5 CAI $494 $587 Sales ($ in millions) SEM Distribution $51 $67 Operating Income +19% +31% $277 $439 Sales $18 $24 Operating Income +58% +33% (1) $174 $234 Sales $25 $32 Operating Income +34% +28% SPECIALTY EBITDA MARGIN EXPANSION 6 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Color acquisition 15.3% 15.2% 16.2% 17.6% 2018 2019 2020 YTD 2021 14.8% 15.2% 17.6% 18.4% 2018 2019 2020 YTD 2021 (1) SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Color synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 7 Legacy CAI 18.9% 18.9% 19.8% 2019 2020 YTD 2021 Legacy Clariant Color 11.9% 13.8% 15.7% 2019 2020 YTD 2021 • Synergy capture driving margin improvement • Favorable mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 35% represents sales from products introduced in the last five years.

Implementing these standards into Supplier performance are important to us and we expect our Suppliers and business partners to communicate these expectations throughout their supply chain by adopting efficient management systems, policies, procedures, and training to uphold the standards and expectations set forth in this Supplier Code of Conduct within their own business operations. This includes measuring performance and setting appropriate goals to promote continuous improvement. • Comply with all applicable environmental, health, safety, and security regulations.

Also, Ohio Revised Code section 1701.70(B) sets forth additional cases in which directors may adopt an amendment to the articles. Note: If amended articles were adopted, they must set forth all provisions required in original articles except that articles amended by directors or shareholders need not contain any statement with respect to initial stated capital.

A brief description of the types of awards which may be granted under the 2017 Plan is set forff th below. Our Board sets the appropriate “tone at the top” when it comes to risk tolerance and management. The 2016 performance goals for our performance measures were set in accordance with our strategic plan framework.

Our Board sets the appropriate “tone at the top” when it comes to risk tolerance and management. The 2023 performance goals were set in accordance with our strategic plan framework and annual operating plan, developed at the end of 2022. The SARs granted in 2023 to the Named Executive Officers are set forth in the 2023 Grants of Plan- Based Awards table of this proxy statement.

GLOBAL ELASTIC & RUBBER PRODUCT MANUFACTURER T O U R N I Q U E T B A N D • Hardness 45, shore A • Thickness 0.5mm and Tensile set

PowerPoint Presentation MEDICAL DEVICE MANUFACTURER O S T O M Y B A G S E A L S • Comply with ISO 10993 and FDA Class II medical device regulations • Offer Good sealing performance • Provide technical supports for processing recommendations • Deliver a high compression set materials to improve comfort • Provided a medical-grade TPE to help the customer meet necessary regulatory specifications and gain market share • Provided technical support during design and the manufacturing process for EVA bonding • Delivered soft-touch feel and excellent sealing performance Versaflex HC Thermoplastic Elastomers - G2705 Formulation KEY REQUIREMENTS WHY AVIENT?